Drugplain

KINEVAC 5 ug/5mL

sincalide · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Bracco Diagnostics Inc.

No Recall History
Plain English

KINEVAC is a injection, powder, lyophilized, for solution containing sincalide at 5 ug/5mL, taken intravenous. Manufactured by Bracco Diagnostics Inc..

Key Facts

Brand Name
KINEVAC
Generic Name
sincalide
NDC Code (Product)
0270-0556
Manufacturer
Bracco Diagnostics Inc.
Strength
5 ug/5mL
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Marketing Status
Application #
NDA017697
Drug Class
Cholecystokinin Analog [EPC]
Marketing Start
07/21/1976

Recall History

No Recall History

Frequently Asked Questions

What is KINEVAC used for?

KINEVAC contains sincalide. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.

Is KINEVAC a controlled substance?

KINEVAC is not classified as a controlled substance by the DEA.

What is the generic name for KINEVAC?

The generic name for KINEVAC is sincalide. There are 3 other brand versions of sincalide.

What is the NDC code for KINEVAC 5 ug/5mL?

The NDC (National Drug Code) for KINEVAC 5 ug/5mL is 0270-0556, listed by Bracco Diagnostics Inc..

Product NDC

0270-0556

Package NDC

0270-0556-15

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)